Saturday 2 October 2021

Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate: targets the outer surface protein A (OspA) of Borrelia burgdorferi... and covers the six OspA serotypes that are prevalent in North America & Europe

submitted by /u/shallah
[link] [comments]

from Health https://ift.tt/3F2Y8PI
via IFTTT

No comments:

Post a Comment